An automated molecular test developed by Cepheid to diagnose tuberculosis (TB) has proven more sensitive than the conventional testing method in a study. As the new diagnostic, Xpert MTB/RIF, is simple to perform and can be used at the point of care, it could be particularly useful in developing ...
Please Login to read the full article.
